Cargando…
Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice
Emerging evidence implicates microbial proteolytic activity in ulcerative colitis (UC), but whether it also plays a role in Crohn’s disease (CD) remains unclear. We investigated the effects of colonizing adult and neonatal germ-free C57BL/6 mice with CD microbiota, selected based on high (CD-HPA) or...
Autores principales: | Santiago, Alba, Hann, Amber, Constante, Marco, Rahmani, Sara, Libertucci, Josie, Jackson, Kyle, Rueda, Gaston, Rossi, Laura, Ramachandran, Rithwik, Ruf, Wolfram, Schertzer, Jon, Caminero, Alberto, Bercik, Premysl, Galipeau, Heather Jean, Verdu, Elena Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158566/ https://www.ncbi.nlm.nih.gov/pubmed/37131291 http://dx.doi.org/10.1080/19490976.2023.2205425 |
Ejemplares similares
-
A3 CROHN’S DISEASE PROTEOLYTIC MICROBIOTA ENHANCES INFLAMMATION THROUGH PAR2 PATHWAY IN GNOTOBIOTIC MICE
por: Hann, A, et al.
Publicado: (2023) -
Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2
por: Caminero, Alberto, et al.
Publicado: (2019) -
A144 CHRONIC DSS LEADS TO ALTERED EXPRESSION OF IRAK4/TPL2 PATHWAYS IN UC-COLONIZED MICE
por: Hann, A, et al.
Publicado: (2022) -
A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
por: Libertucci, J, et al.
Publicado: (2022) -
The emerging roles of bacterial proteases in intestinal diseases
por: Caminero, Alberto, et al.
Publicado: (2023)